Cichoriin
CAS No. 531-58-8
Cichoriin ( —— )
产品货号. M29290 CAS No. 531-58-8
菊苣苷是一种光敏化合物,可作为草药光敏剂治疗大鼠良性乳腺肿瘤。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥988 | 有现货 |
|
10MG | ¥1588 | 有现货 |
|
25MG | ¥2811 | 有现货 |
|
50MG | ¥4180 | 有现货 |
|
100MG | ¥5962 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Cichoriin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述菊苣苷是一种光敏化合物,可作为草药光敏剂治疗大鼠良性乳腺肿瘤。
-
产品描述Cichoriin is a photosensitive compound, it could be used as herbal photosensitizing agent in treating benign breast tumor in rats.(In Vitro):METHODS AND RESULTS:Four flavonoids including kaempferol (1), isoscutellarin (2), umbelliferone (3) and Cichoriin (4) have been isolated from Streptomyces sp. Tc052, an endophyte in the root tissue of Alpinia galanga Swartz. The evaluation for protective effect of compounds 1-4 against glutamate-induced cytotoxicity in hippocampal HT22 cell line was conducted, Compounds 1 and 2 showed significant effective protection ratios of 62.4+2.8 and 55.3+3.4%, respectively, at a concentration of 100 μM, whereas compounds 3-4 were inactive. Compounds 1 and 2 showed potent scavenging effects on DPPH radical exhibiting IC50 value of 60.74 and 75.65 μM, respectively. CONCLUSIONS: These results suggest that compounds 1 and 2 may possess the neuroprotective activity against oxdative cellular injuries.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number531-58-8
-
分子量340.28
-
分子式C15H16O9
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (293.88 mM)
-
SMILESOC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc1cc(OC(C=C2)=O)c2cc1O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Neurokinin B TFA
Neurokinin B TFA belongs to the tachykinin family.Neurokinin B binds to a series of GPCR, including neurokinin receptors 1 (NK1R), NK2R, and nk3r, to modulate their biological effects
-
4-Propionamidophenol
4-丙酰胺苯酚是一种对乙酰氨基苯酚类似物。
-
2-Hydroxy-1-Methoxya...
2-Hydroxy-1-Methoxyaporphine can inhibit CYP2D6 activity, it also increase the glucose consumption significantly as rosiglitazone.